Authorized purpose: Process, review, analyze, communicate, and exchange multidimensional CT or MR images, including preliminary segmentation of normal anatomy, for preoperative surgical planning and intraoperative display; healthcare professionals make all final patient-management decisions. Machine-learning algorithms are for adults aged 22 years and older, while images for patients under 22 or of unknown age are generated without machine learning.
Clinical role
3D CT/MR image generation and interactive review for preoperative planning and intraoperative display, with preliminary normal-anatomy segmentation and measurement support; the device is not integrated with surgical instruments for real-time guidance or navigation.
Images and patients
CT/CTA; MRI · Multi-region normal anatomy represented in CT or MR images; validated examples include prostate, bladder, neurovascular bundles, kidney, artery, and vein
Key limitation
Keep in mind: Machine-learning algorithms are limited to adults aged 22 years and older; under-22 or unknown-age 3D images are generated without machine learning. Segmentations are preliminary and limited to normal anatomy, and the clinician retains final management responsibility. The device is not intended to provide semi-automated segmentation of abnormal anatomy or integrate with surgical instruments for real-time guidance/navigation; specific current interfaces and deployment are not established.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Process, review, analyze, communicate, and exchange multidimensional CT or MR images, including preliminary segmentation of normal anatomy, for preoperative surgical planning and intraoperative display; healthcare professionals make all final patient-management decisions. Machine-learning algorithms are for adults aged 22 years and older, while images for patients under 22 or of unknown age are generated without machine learning.
Which images or clinical context are in scope?Modality: CT/CTA; MRI Anatomy or clinical context: Multi-region normal anatomy represented in CT or MR images; validated examples include prostate, bladder, neurovascular bundles, kidney, artery, and vein Input: Existing multidimensional digital images acquired from CT or MR imaging devices; patient age determines whether machine-learning algorithms are used, with no machine learning for patients under 22 or of unknown age.
Who uses it?Intended users: Healthcare professionals; company personnel generate the 3D images in the described service workflow
What does the software produce?Output: Three-dimensional images viewable through compatible mobile and desktop viewer applications, external displays, or compatible off-the-shelf VR headsets; users can manipulate the images, selectively show or hide anatomical structures, view measurements of or between structures, and review preliminary segmentations of normal anatomy.
What is its most important limitation?Key limitation: Machine-learning algorithms are limited to adults aged 22 years and older; under-22 or unknown-age 3D images are generated without machine learning. Segmentations are preliminary and limited to normal anatomy, and the clinician retains final management responsibility. The device is not intended to provide semi-automated segmentation of abnormal anatomy or integrate with surgical instruments for real-time guidance/navigation; specific current interfaces and deployment are not established.
Clinical takeaway. Clinical role: Process, review, analyze, communicate, and exchange multidimensional CT or MR images, including preliminary segmentation of normal anatomy, for preoperative surgical planning and intraoperative display; healthcare professionals make all final patient-management decisions. Machine-learning algorithms are for adults aged 22 years and older, while images for patients under 22 or of unknown age are generated without machine learning.
Evidence takeaway. Evidence from the reviewed source record: FDA K233568 reports software verification and validation using 141 actual CT or MR imaging studies, with training and testing kept independent at the scanning-institution level. Four machine-learning models were compared with medical-professional segmentations: prostate DSC 0.87, bladder DSC 0.90, neurovascular-bundle HD-95 7.8 mm, kidney DSC 0.89 for CT abdomen and 0.87 for MR abdomen, artery DSC 0.87 for CT abdomen, 0.83 for MR abdomen, and 0.85 for CT chest, and vein DSC 0.86 for CT abdomen, 0.81 for MR abdomen, and 0.81 for CT chest. Volume, diameter, and two-point-distance measurements were verified within a mean difference of plus or minus 10%.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Process, review, analyze, communicate, and exchange multidimensional CT or MR images, including preliminary segmentation of normal anatomy, for preoperative surgical planning and intraoperative display; healthcare professionals make all final patient-management decisions. Machine-learning algorithms are for adults aged 22 years and older, while images for patients under 22 or of unknown age are generated without machine learning.
3D CT/MR image generation and interactive review for preoperative planning and intraoperative display, with preliminary normal-anatomy segmentation and measurement support; the device is not integrated with surgical instruments for real-time guidance or navigation.
Existing multidimensional digital images acquired from CT or MR imaging devices; patient age determines whether machine-learning algorithms are used, with no machine learning for patients under 22 or of unknown age.
Three-dimensional images viewable through compatible mobile and desktop viewer applications, external displays, or compatible off-the-shelf VR headsets; users can manipulate the images, selectively show or hide anatomical structures, view measurements of or between structures, and review preliminary segmentations of normal anatomy.
Machine-learning algorithms are limited to adults aged 22 years and older; under-22 or unknown-age 3D images are generated without machine learning. Segmentations are preliminary and limited to normal anatomy, and the clinician retains final management responsibility. The device is not intended to provide semi-automated segmentation of abnormal anatomy or integrate with surgical instruments for real-time guidance/navigation; specific current interfaces and deployment are not established.
FDA K233568 reports software verification and validation using 141 actual CT or MR imaging studies, with training and testing kept independent at the scanning-institution level. Four machine-learning models were compared with medical-professional segmentations: prostate DSC 0.87, bladder DSC 0.90, neurovascular-bundle HD-95 7.8 mm, kidney DSC 0.89 for CT abdomen and 0.87 for MR abdomen, artery DSC 0.87 for CT abdomen, 0.83 for MR abdomen, and 0.85 for CT chest, and vein DSC 0.86 for CT abdomen, 0.81 for MR abdomen, and 0.81 for CT chest. Volume, diameter, and two-point-distance measurements were verified within a mean difference of plus or minus 10%.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
FDA K233568 reports software verification and validation using 141 actual CT or MR imaging studies, with training and testing kept independent at the scanning-institution level. Four machine-learning models were compared with medical-professional segmentations: prostate DSC 0.87, bladder DSC 0.90, neurovascular-bundle HD-95 7.8 mm, kidney DSC 0.89 for CT abdomen and 0.87 for MR abdomen, artery DSC 0.87 for CT abdomen, 0.83 for MR abdomen, and 0.85 for CT chest, and vein DSC 0.86 for CT abdomen, 0.81 for MR abdomen, and 0.81 for CT chest. Volume, diameter, and two-point-distance measurements were verified within a mean difference of plus or minus 10%.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
Ceevra Reveal 3+ regulatory performance study summary
DesignStand-Alone Performance
PopulationAdult
Scopeexact submission
Tested version3
Samplen=141
IndependenceIndependence not established
K233568
ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K233568. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Existing multidimensional digital images acquired from CT or MR imaging devices; patient age determines whether machine-learning algorithms are used, with no machine learning for patients under 22 or of unknown age.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: The FDA packet describes communication and media interchange of CT/MR images plus compatible mobile and desktop applications, external displays, and off-the-shelf VR headset viewing. It does not establish a specific current PACS, RIS, EHR, interface version, or deployment topology.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Unresolved route: Not established for the exact route.
Scope: Exact FDA submission. The reviewed sources do not establish the current exact-release hosting topology, data flow, region, tenancy, or disaster-recovery configuration.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-09-08 ·
Returned objects
Source context, not route validation: Three-dimensional images viewable through compatible mobile and desktop viewer applications, external displays, or compatible off-the-shelf VR headsets; users can manipulate the images, selectively show or hide anatomical structures, view measurements of or between structures, and review preliminary segmentations of normal anatomy.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: Three-dimensional images viewable through compatible mobile and desktop viewer applications, external displays, or compatible off-the-shelf VR headsets; users can manipulate the images, selectively show or hide anatomical structures, view measurements of or between structures, and review preliminary segmentations of normal anatomy.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
The FDA packet describes communication and media interchange of CT/MR images plus compatible mobile and desktop applications, external displays, and off-the-shelf VR headset viewing. It does not establish a specific current PACS, RIS, EHR, interface version, or deployment topology.
ACR AI Central provides an exact-submission model card for Ceevra Reveal 3+; FDA labeling remains controlling for clinical use, limitations, and performance.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
Multi-region normal anatomy represented in CT or MR images; validated examples include prostate, bladder, neurovascular bundles, kidney, artery, and vein
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-20Last searched
21Fields reviewed
9Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not verified - checked 2026-09-08 - Exact FDA submission
No public price or quote for the exact K233568 configuration was established in this review.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-09-08 - Exact FDA submission
No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
Deployment: Not verified - checked 2026-09-08 - Exact FDA submission
The reviewed sources do not establish the current exact-release hosting topology, data flow, region, tenancy, or disaster-recovery configuration.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Security: Not verified - checked 2026-09-08 - Exact FDA submission
Exact-release security controls, data retention, hosting boundaries, and scoped assurance documentation require vendor confirmation.
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-09-08 - Exact FDA submission
Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
Monitoring: Not verified - checked 2026-09-08 - Exact FDA submission
Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
Authorized purpose: View, post-process, and qualitatively and quantitatively evaluate cardiovascular MR and CT images in DICOM format to obtain diagnostic information as part of a comprehensive diagnostic decision-making process.
Modality
CT/CTA; MRI
Anatomy
Cardiovascular system; heart, coronary and adjacent vessels, and cardiac valves
Authorized purpose: Manages, views, processes, stores, transfers, filters, manipulates, and quantitatively measures DICOM and non-DICOM images and data, with optional Cardio AI and Oncology AI support.
Authorized purpose: Support-tool image processing for quantitative cardiovascular assessment and oncologic lesion evaluation, quantification, follow-up, and documentation to aid trained healthcare professionals in diagnosis; the software does not directly generate a diagnosis or potential findings.
Modality
CT/CTA; MRI
Anatomy
Heart and major vessels for Cardio AI; oncology lesion anatomy is not further specified in the FDA statement.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.